Your browser doesn't support javascript.
loading
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD®) in Asian men with prostate cancer.
Malek, Rohan; Wu, Sheng-Tang; Serrano, Dennis; Tho, Tran; Umbas, Rainy; Teoh, Jeremy; Lojanapiwat, Bannakji; Ong, Teng Aik; On, Weber Kam; Thai, Sam Minh; Kim, Janet; Pophale, Rupesh; Chiong, Edmund.
Affiliation
  • Malek R; Department of Urology, Hospital Selayang, Selangor, Malaysia.
  • Wu ST; Division of Urology, Department of Surgery, Tri-Service General Hospital, Taipei.
  • Serrano D; Section of Urology, Department of Surgery, Manila Doctors Hospital, Manila, Philippines.
  • Tho T; Chemotherapy Department, Ho Chi Minh City University Medical Centre, Ho Chi Minh City, Vietnam.
  • Umbas R; Department of Urology, Dr. Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia.
  • Teoh J; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
  • Lojanapiwat B; Department of Surgery, Chiang Mai University, Chiang Mai, Thailand.
  • Ong TA; University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • On WK; Singapore General Hospital, Singapore, Singapore.
  • Thai SM; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Vietnam.
  • Kim J; Medical Affairs Statistics, Astellas Pharma Inc., Northbrook, IL, USA.
  • Pophale R; Department of Oncology, Astellas Pharma Inc., Singapore, Singapore.
  • Chiong E; Department of Urology, National University Hospital, Department of Surgery, National University of Singapore, Singapore, Singapore.
Transl Androl Urol ; 11(2): 179-189, 2022 Feb.
Article in En | MEDLINE | ID: mdl-35280654

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Aspects: Patient_preference Language: En Journal: Transl Androl Urol Year: 2022 Document type: Article Affiliation country: Malaysia Country of publication: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Aspects: Patient_preference Language: En Journal: Transl Androl Urol Year: 2022 Document type: Article Affiliation country: Malaysia Country of publication: China